Endovascular Management of Mycotic Pseudoaneurysm After Pancreas Transplantation: Case Report and Literature Review

Jinna Yao1, Mauro Vicaretti2, Taina Lee3

  • 1Department of Urology, Westmead Hospital, Sydney, Australia; Department of Surgery, Westmead Hospital, Sydney, Australia; Discipline of Surgery, University of Sydney Medical School, Sydney, Australia; National Pancreas Transplant Unit, Westmead Hospital, Sydney, Australia.

Transplantation Proceedings
|February 22, 2020
PubMed
Abstract

Insights

Mycotic pseudoaneurysms after pancreas transplant are rare. Endovascular repair can be a useful initial treatment, but often requires further surgery, especially in high-risk patients.

Area of Science:

  • Transplantation Surgery
  • Vascular Surgery
  • Infectious Diseases

Background:

  • Mycotic pseudoaneurysms are infrequent but serious complications following pancreas transplantation.
  • Early diagnosis and prompt treatment, including surgery and antibiotics, are crucial for successful management.
  • Traditional treatment involves open repair, but endovascular repair offers a less invasive alternative.

Observation:

  • This study reports a case of mycotic pseudoaneurysm in a pancreas transplant recipient successfully managed with endovascular repair.
  • A systematic literature review identified 14 additional cases of mycotic aneurysms in transplant recipients treated with endovascular repair.

Findings:

  • Endovascular repair served as a viable bridging strategy in the reported case, facilitating definitive surgical treatment.
  • In the literature, 54.5% of patients treated initially with endovascular stents required subsequent graft excision.
  • Continued sepsis led to stent excision in 28.6% of cases, highlighting potential complications.

Implications:

  • Endovascular management can be cautiously employed in high-risk transplant recipients as a temporary measure.
  • Prolonged antibiotic therapy and close clinical monitoring are essential.
  • A low threshold for allograft excision is recommended if clinical deterioration occurs.